Copyright: ©Author(s) 2026.
World J Psychiatry. Aug 19, 2026; 16(8): 120278
Published online Aug 19, 2026. doi: 10.5498/wjp.120278
Published online Aug 19, 2026. doi: 10.5498/wjp.120278
Figure 2 Receiver operating characteristic curves of serum nerve growth factor-related indicators and their combinations for predicting response to antipsychotic drug treatment.
A: Receiver operating characteristic (ROC) curve of sensitivity vs specificity of baseline nerve growth factor (NGF); B: ROC curve of sensitivity vs specificity of NGF at 2 weeks after onset of antipsychotic treatment; C: ROC curve of sensitivity vs specificity of early NGF changes; D: ROC curve of sensitivity vs specificity of combinations of baseline NGF, NGF at 2 weeks after onset of antipsychotic treatment, early NGF changes, and early psychopathological improvement in response to antipsychotic drug treatment. Early nerve growth factor changes: Nerve growth factor at 2 weeks after onset of antipsychotics treatment - baseline nerve growth factor. AUC: Areas under the curve; NGF0: Baseline nerve growth factor; NGF1: Nerve growth factor at 2 weeks after onset of antipsychotics treatment.
- Citation: Xiao WH, Wang ML, Chen KY, Yu DD, Zhao YQ, Sun JR. Assessment of nerve growth factor levels and clinical indicators for outcome prediction in first-episode schizophrenia. World J Psychiatry 2026; 16(8): 120278
- URL: https://www.wjgnet.com/2220-3206/full/v16/i8/120278.htm
- DOI: https://dx.doi.org/10.5498/wjp.120278